These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 895374

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Comparison of the locomotor stimulant mechanisms of action of d-amphetamine and d-amphetamine plus l-dopa: possible involvement of serotonin.
    Neuburg J, Thut PD.
    Biol Psychiatry; 1974 Apr; 8(2):139-50. PubMed ID: 4276374
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Selective reserpine-resistant accumulation of catecholamines in central dopamine neurones after DOPA administration.
    Lidbrink P, Jonsson G, Fuxe K.
    Brain Res; 1974 Mar 08; 67(3):439-56. PubMed ID: 4470434
    [No Abstract] [Full Text] [Related]

  • 6. The role of the adrenergic system in the action of L-DOPA on brain serotonin.
    Algeri S, Cerletti C.
    Adv Biochem Psychopharmacol; 1974 Mar 08; 10():257-9. PubMed ID: 4846542
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Enhanced cortical dopamine output and antipsychotic-like effect of raclopride with adjunctive low-dose L-dopa.
    Eltayb A, Wadenberg ML, Svensson TH.
    Biol Psychiatry; 2005 Aug 15; 58(4):337-43. PubMed ID: 16102547
    [Abstract] [Full Text] [Related]

  • 10. Effect of long-term L-dopa administration on brain biogenic amines and behavior in the rat.
    Narotzky R, Griffith D, Stahl S, Bondareff W, Zeller EA.
    Exp Neurol; 1973 Feb 15; 38(2):218-30. PubMed ID: 4690179
    [No Abstract] [Full Text] [Related]

  • 11. L-DOPA: effect on concentrations of dopamine, norepinephrine, and serotonin in brains of mice.
    Everett GM, Borcherding JW.
    Science; 1970 May 15; 168(3933):847-50. PubMed ID: 5444060
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. L-DOPA attenuates hyperactivity of Roborovskii hamsters.
    Kabuki Y, Shigemi K, Hamasu K, Furuse M.
    Behav Pharmacol; 2009 May 15; 20(3):260-4. PubMed ID: 19404194
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A comparison of the effects of decarboxylase inhibitors on L-dopa-induced circling behavior and the conversion of dopa to dopamine in the brain.
    Goodale DB, Moore KE.
    Life Sci; 1976 Sep 01; 19(5):701-6. PubMed ID: 957902
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of alpha-methyl dopa on the reserpine-induced suppression of motor activity and the conditioned avoidance response.
    Uretsky NJ, Seiden LS.
    J Pharmacol Exp Ther; 1969 Jul 01; 168(1):153-62. PubMed ID: 4307318
    [No Abstract] [Full Text] [Related]

  • 20. Further studies on the behavioural and biochemical interaction between caffeine and L-DOPA.
    Strömberg U, Waldeck B.
    J Neural Transm; 1973 Jul 01; 34(4):241-52. PubMed ID: 4359657
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.